These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9245192)
1. [Serotonergic function in endogeneity of depression]. González-Pinto A; López-Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; Elizagárate E; Pérez de Heredia JL Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):73-8. PubMed ID: 9245192 [TBL] [Abstract][Full Text] [Related]
2. [The clomipramine test and subtypes of depression]. González-Pinto A; López Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; García Godoy MJ Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):303-9. PubMed ID: 9054201 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects. Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933 [TBL] [Abstract][Full Text] [Related]
4. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity. Lykouras L; Markianos M; Hatzimanolis Y Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381 [TBL] [Abstract][Full Text] [Related]
5. Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis. Cordes J; Larisch R; Henning U; Thünker J; Werner C; Orozco G; Mayoral F; Rivas F; Auburger G; Tosch M; Rietschel M; Gaebel W; Müller HW; Klimke A Depress Anxiety; 2009; 26(8):E111-9. PubMed ID: 19288582 [TBL] [Abstract][Full Text] [Related]
6. Decreased 5-HT-mediated prolactin release in major depression. Anderson IM; Ware CJ; da Roza Davis JM; Cowen PJ Br J Psychiatry; 1992 Mar; 160():372-8. PubMed ID: 1562864 [TBL] [Abstract][Full Text] [Related]
7. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course. Markianos M; Hatzimanolis J; Lykouras L Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):172-6. PubMed ID: 12242578 [TBL] [Abstract][Full Text] [Related]
8. Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge. Theodorakis GN; Markianos M; Livanis EG; Zarvalis E; Flevari P; Kremastinos DT Circulation; 1998 Dec; 98(24):2724-30. PubMed ID: 9851959 [TBL] [Abstract][Full Text] [Related]
9. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response. Cleare AJ; Murray RM; O'Keane V Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879 [TBL] [Abstract][Full Text] [Related]
11. Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients. Markianos M; Hatzimanolis J; Lykouras L Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):166-71. PubMed ID: 12242577 [TBL] [Abstract][Full Text] [Related]
12. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. O'Keane V; Dinan TG Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948 [TBL] [Abstract][Full Text] [Related]
13. Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression. Abel KM; O'Keane V; Murray RM; Cleare AJ Psychoneuroendocrinology; 1997 Oct; 22(7):539-48. PubMed ID: 9373887 [TBL] [Abstract][Full Text] [Related]
14. State and trait abnormalities in serotonin function in major depression. Bhagwagar Z; Whale R; Cowen PJ Br J Psychiatry; 2002 Jan; 180():24-8. PubMed ID: 11772847 [TBL] [Abstract][Full Text] [Related]
15. Decreased plasma serotonin in melancholic patients: a study with clomipramine. Sarrias MJ; Artigas F; Martínez E; Gelpí E; Alvarez E; Udina C; Casas M Biol Psychiatry; 1987 Dec; 22(12):1429-38. PubMed ID: 3676370 [TBL] [Abstract][Full Text] [Related]
16. Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. Price LH; Charney DS; Delgado PL; Heninger GR Am J Psychiatry; 1991 Nov; 148(11):1518-25. PubMed ID: 1928466 [TBL] [Abstract][Full Text] [Related]
17. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder. Foster RH; Goa KL CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224 [TBL] [Abstract][Full Text] [Related]
18. The effects of age, gender, and season on serotonergic function in healthy subjects. Golden RN; Gilmore JH; Ekstrom RD; Knight B; Ruegg RG; Miller HL; Carson SW Prog Neuropsychopharmacol Biol Psychiatry; 1996 Nov; 20(8):1315-23. PubMed ID: 9004339 [TBL] [Abstract][Full Text] [Related]
19. Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine. Lee KS; Na YG; Dean-McKinney T; Klausner AP; Tuttle JB; Steers WD J Urol; 2003 Nov; 170(5):2067-71. PubMed ID: 14532855 [TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone. Markianos M; Hatzimanolis J; Lykouras L Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]